OVERCOMING DRUG RESISTANCE WITH SGI-1776: A NOVEL PIM KINASE INHIBITOR WITH POTENT PRECLINICAL ACTIVITY IN ACUTE MYELOID LEUKEMIA

  • Michael O'Dwyer

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume94
Publication statusPublished - 1 Jun 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this